Dr. Ross Murdoch
Dr Murdoch joined Avecho as CEO in January 2015. He retired as CEO in 2019 to become CEO of Tasmanian Alkaloids, but remains on the Board of Avecho as an Independent Director.
He has more than 25 years experience as a leader within the global Healthcare, Pharmaceutical and Biotechnology Industry. He has held senior management and executive positions in Australia, USA and Europe, with responsibility for the strategy, development and commercialisation of products, product portfolios and the building and rebuilding of new and existing businesses.
Highlights of his career include Senior Vice President at Shire Pharmaceuticals (one of the world’s leading Specialty Pharmaceutical companies), based in the USA and Switzerland, where he founded and grew both the Emerging Products Business and Haematology Business, and President and COO of Prana Biotechnology Limited based in Australia.
Dr Murdoch has a BSc degree with honours from Monash University, a PhD in Clinical Pharmacology from the University of Melbourne, and additional postgraduate training in Health Economics from Monash University Business School